102 related articles for article (PubMed ID: 21786248)
21. Disruption of clock gene expression in human colorectal liver metastases.
Huisman SA; Ahmadi AR; IJzermans JN; Verhoef C; van der Horst GT; de Bruin RW
Tumour Biol; 2016 Oct; 37(10):13973-13981. PubMed ID: 27492458
[TBL] [Abstract][Full Text] [Related]
22. [Expression of glucose transporter 1 in human laryngeal squamous cell carcinoma and its clinical significance].
Jiang J; Hu G; Wu W; Kang N
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 24(24):1119-22. PubMed ID: 21395180
[TBL] [Abstract][Full Text] [Related]
23. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
Mori Y; Tsukinoki K; Yasuda M; Miyazawa M; Kaneko A; Watanabe Y
Oral Oncol; 2007 Jul; 43(6):563-9. PubMed ID: 17071132
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
Yuan H; Tu SL; He XJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
Shen X; Bai Y; Luo B; Zhou X
Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of BTF3 expression in colorectal cancer.
Wang CJ; Frånbergh-Karlson H; Wang DW; Arbman G; Zhang H; Sun XF
Tumour Biol; 2013 Aug; 34(4):2141-6. PubMed ID: 23532689
[TBL] [Abstract][Full Text] [Related]
31. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
[TBL] [Abstract][Full Text] [Related]
32. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.
Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F
Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
35. Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
Ahopelto K; Laitinen A; Hagström J; Böckelman C; Haglund C
Oncology; 2020; 98(9):643-652. PubMed ID: 32434192
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
37. Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.
Komaki S; Sugita Y; Furuta T; Yamada K; Moritsubo M; Abe H; Akiba J; Miyagi N; Nakamura H; Miyoshi H; Ohshima K; Morioka M
J Neuropathol Exp Neurol; 2019 May; 78(5):389-397. PubMed ID: 30990881
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer.
Liu H; Xu Y; Zhang Q; Yang H; Shi W; Liu Z; Li K; Gong Z; Ning S; Li S; Chen Y
Surg Oncol; 2017 Mar; 26(1):13-20. PubMed ID: 28317580
[TBL] [Abstract][Full Text] [Related]
39. Inter- and intra-tumoral relationships between vasculature characteristics, GLUT1 and budding in colorectal carcinoma.
Mezheyeuski A; Nerovnya A; Bich T; Tur G; Ostman A; Portyanko A
Histol Histopathol; 2015 Oct; 30(10):1203-11. PubMed ID: 25811313
[TBL] [Abstract][Full Text] [Related]
40. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
